Researchers develop platform allowing mass-scale production of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Researchers presented a scalable lipid nanoparticle production (SCALAR) platform to develop SARS-CoV-2 mRNA lipid nanoparticle vaccines.

Candid inks three T cell engager deals; PepGen trial put on hold

Plus, news about Foghorn Therapeutics, Incyte, BioNTech, Galderma, Basilea, Innovia, Pharming, bit.bio, Promise Bio, Outlook Therapeutics and Trevi Therapeutics: Candid Therapeutics’ trio of T cell

December 17, 2024

What we know about H5N1 bird flu in cows — and the risk to humans

The discovery of H5N1 bird flu in U.S. cattle — and the news that at least one person in Texas has been infected, apparently through

April 3, 2024

Orano Med unveils radiopharma manufacturing plant in Indianapolis – Pharmaceutical Technology

Orano Med’s CEO Julien Dodet speaking at the inauguration of the ATLab in Indianapolis, US. Credit: Orano Med via LinkedIn. As the radiopharmaceuticals space continues

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.